GQG Partners’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213M | Sell |
272,594
-1,556,859
| -85% | -$1.21B | 0.3% | 49 |
|
|
2025
Q1 | $1.51B | Sell |
1,829,453
-2,705,511
| -60% | -$2.23B | 2.41% | 14 |
|
|
2024
Q4 | $3.5B | Sell |
4,534,964
-275,876
| -6% | -$213M | 5.2% | 3 |
|
|
2024
Q3 | $4.26B | Buy |
4,810,840
+803,141
| +20% | +$712M | 6.68% | 3 |
|
|
2024
Q2 | $3.63B | Buy |
4,007,699
+158,813
| +4% | +$144M | 5.5% | 5 |
|
|
2024
Q1 | $2.99B | Buy |
3,848,886
+648,094
| +20% | +$504M | 4.82% | 5 |
|
|
2023
Q4 | $1.87B | Sell |
3,200,792
-67,235
| -2% | -$39.2M | 3.95% | 7 |
|
|
2023
Q3 | $1.76B | Buy |
3,268,027
+118,821
| +4% | +$63.8M | 4.06% | 7 |
|
|
2023
Q2 | $1.48B | Buy |
3,149,206
+172,407
| +6% | +$80.9M | 3.4% | 13 |
|
|
2023
Q1 | $1.02B | Buy |
2,976,799
+1,329,081
| +81% | +$456M | 2.68% | 16 |
|
|
2022
Q4 | $603M | Buy |
1,647,718
+53,270
| +3% | +$19.5M | 1.63% | 21 |
|
|
2022
Q3 | $515M | Sell |
1,594,448
-37,001
| -2% | -$12M | 1.49% | 23 |
|
|
2022
Q2 | $529M | Sell |
1,631,449
-63,772
| -4% | -$20.7M | 1.3% | 25 |
|
|
2022
Q1 | $485M | Buy |
1,695,221
+29,522
| +2% | +$8.45M | 1.13% | 27 |
|
|
2021
Q4 | $460M | Buy |
1,665,699
+33,940
| +2% | +$9.37M | 1.14% | 31 |
|
|
2021
Q3 | $377M | Sell |
1,631,759
-72,978
| -4% | -$16.9M | 1.03% | 31 |
|
|
2021
Q2 | $391M | Sell |
1,704,737
-299,105
| -15% | -$68.6M | 1.15% | 30 |
|
|
2021
Q1 | $374M | Sell |
2,003,842
-60,037
| -3% | -$11.2M | 1.37% | 27 |
|
|
2020
Q4 | $348M | Buy |
2,063,879
+1,476,146
| +251% | +$249M | 1.19% | 29 |
|
|
2020
Q3 | $87M | Buy |
+587,733
| New | +$87M | 0.3% | 50 |
|